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Cdk1 plays an important role in undifferentiated ES cells, but the underlying mechanism remains
unclear. This study explores how Cdk1 collaborates with Oct4 to inhibit differentiation in mouse
ES cells. We show a direct interaction between Cdk1 and Oct4, whereas other Cdk members, includ-
ing Cdk2 and Cdk4, fail to associate with Oct4. By immunocytochemistry we show that Cdk1 and
Oct4 co-localize in ES cells. The biological function of the Cdk1–Oct4 complex was also addressed.
We found that Cdk1 enhances the binding of Oct4 on the trophectoderm marker Cdx2 and promotes
Cdx2 repression. This regulation is independent of Cyclins and of the kinase activity of Cdk1. Our
study explains how Cdk1 and Oct4 interplay to inhibit ES cell differentiation into trophectoderm
and thereby maintain stemness.
Structured summary of protein interactions:
Cdk1 physically interacts with Oct4 by anti tag coimmunoprecipitation (View interaction)
Oct4 binds to SOX-2 by pull down (View interaction)
Cdk1 physically interacts with Oct4 and cyclin-B1 by anti bait coimmunoprecipitation (View interaction)
Oct4 binds to Cdk1 by pull down (View interaction)
Cdk1 and Oct4 colocalize by ﬂuorescence microscopy (View interaction)
Oct4 physically interacts with Sox2 by anti bait coimmunoprecipitation (View interaction)
Crown Copyright  2012 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction
Embryonic stem (ES) cells, which can be derived from the inner
cell mass (ICM) of early blastocysts [1], are pluripotent and capable
of self-renewal [2]. The embryonic origin allows ES cells to serve as
a good model for studying the early embryogenesis. On the other
hand, the unique properties of ES cells decide their potential appli-
cation in cell transplantation, tissue engineering and drug develop-
ment [3–5]. Understanding the molecular mechanisms underlying
self-renewal and pluripotency of ES cells is critical to achieve their
potentials both in basic research and clinic application.d by Elsevier B.V. on behalf of Fede
Sciences, The Capital Normal
ct, #732 Lab Building, Beijing
e Capital Normal University,
ab Building, Beijing 100048,
Xiao), zhangww@mail.cnu.In recent years, signiﬁcant progress has been made toward
understanding undifferentiation- or differentiation-related factors
regulating the characteristics of ES cells, including core transcrip-
tion factors, such as Oct4 [6], Sox2 [7], and Nanog [8,9]. In vivo,
these factors exhibit restricted expression proﬁles and play essen-
tial roles in the process of early embryo development. In ES cells,
these regulators are critical in maintaining the stemness. Oct4, also
known as Pou5f1, is a key player in maintaining the pluripotent
state of self-renewing ES cells. ES cells are particularly sensitive
to dosage alterations in Oct4: twofold induction of Oct4 led to ES
cells differentiation into primitive endoderm and mesoderm. Loss
of Oct4, on the other hand, triggers the formation of trophectoderm
lineages [10]. In vivo, the proper development of the ICM and
trophectoderm requires the interplay between Oct4 and caudal-
type homeodomain transcription factor Cdx2. Cdx2 is initially co-
expressed with Oct4 and they form a complex for the reciprocal
repression of their target genes in ES cells. Cdx2 can directly bind
to the Oct4 promoter to inhibit its transcription [11]. Elevation of
Cdx2 level in ES cells represses the gene activity of Oct4 and re-
sulted in cell differentiation into trophectoderm [11]. Duringration of European Biochemical society. All rights reserved.
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the expression of Cdx2 is highly rich in trophectoderm [12]. Their
restricted expression proﬁles highlight the importance of Oct4 and
Cdx2 in regulating early embryonic development.
The ability of mammalian cells to divide is mainly attributed to
the presence of Cyclin-dependent kinases (Cdks) and their binding
partners, Cyclins [13]. Among the Cdks, Cdk1 is unique due to the
observation that Cdk1 alone is sufﬁcient to drive the cell cycle pro-
gress [14], which indicates that Cdk1 can compensate other Cdks in
cell cycle. Its central role in cell cycle regulation may serve to ex-
plain why Cdk1 deletion leads to early embryonic lethality [14].
Interestingly, several studies reported that Cdk1 is involved in reg-
ulating cell differentiation. Ullah et al. showed that Cdk1 can re-
press the differentiation of trophectoderm stem cells into giant
cells [15]. Inhibition of Cdk1 mediated by either speciﬁc inhibitor
RO3306 or RNA interference leads to apoptosis of the ES cells
[15]. Our previous study characterized the Cdk1-depleted ES cells
and found that Cdk1 is indispensable for the undifferentiated
self-renewing state of ES cells. Depletion of Cdk1 results in de-
crease of self-renewal genes and increase of differentiation-related
genes [16]. However, this study could not distinguish whether its
regulation on these genes is direct or indirect. Of note, Wang and
his colleagues used afﬁnity puriﬁcation coupled with mass spec-
trometry to identify Cdk1 as a member of the Oct4 interactome
[17]. Thus, we hypothesized that Cdk1 functions through its phys-
ical interaction with Oct4 so as to transcriptionally regulate down-
stream stemness- or differentiation-related target genes.
In this study, we presented the evidence that Cdk1 is an inter-
action partner of Oct4. They can form a complex through a direct
protein–protein association. By using the immunocytochemistry
(ICC) assay, we also detected co-localization of Cdk1 and Oct4 in
ES cells. More importantly, their interaction was required for
Oct4-mediated repression of Cdx2 transcription. Interestingly, this
role of Cdk1 in ES cells seemed cell-cycle independent. These ﬁnd-
ings explained the detailed mechanism underlying Cdk1 function
in ES cells, and point to a novel role for Cdk1 in transcriptional reg-
ulation and differentiation repression.
2. Materials and methods
2.1. Cell culture
Mouse E14 ES cells (ATCC) were cultured under a feeder-free
condition at 37 C with 5% CO2. The cells were maintained on gel-
atin-coated dishes in Dulbecco’s modiﬁed Eagle medium (DMEM;
GIBCO), supplemented with 15% heat-inactivated fetal bovine ser-
um (FBS; GIBCO), 0.1 mM b-mercaptoethanol (GIBCO), 2 mM L-glu-
tamine, 0.1 mM MEM non-essential amino acid, 5000 U/ml
penicillin/streptomycin and 1000 U/ml of LIF (Chemicon).
2.2. Knockdown plasmids and cell transfection
Oct4 and Cdk1 knockdown plasmid was constructed according
to the previous reports [18,19]. Transfection of shRNA oligo was
performed using Lipofectamine 2000 (Invitrogen). For knockdown,
4 lg of shRNA plasmids were transfected into ES cells on 35 mm
plates, and maintained for 2–6 days prior to RNA or protein
harvesting.
2.3. Protein extraction and Western blotting
Total protein was extracted by lysing cells with the whole cell
extraction buffer (Tris, 50 mM; Nacl, 150 mM; NP40, 1%; Glycerol,
10%; EDTA, 1 mM; PMSF, 1 mM). Thirty micrograms of the total
protein were separated by SDS–PAGE and transferred to PVDF
membrane. The membrane was blocked with 5% milk and probedwith speciﬁc primary antibodies and secondary antibodies. The
blots were developed with ECL Advance Western Blotting Detec-
tion Kit (Amersham). Anti-Cdk1 antibodies (Bioworld, BS1820; Cell
Signaling, Y15; Abcam, E161, Santa Cruz, sc-53219), anti-Oct4 anti-
body (Santa Cruz, sc-8628), anti-Oct4 antibody (Santa Cruz, sc-
8628), anti-HA probe antibody (Santa Cruz, sc-7392), anti-Flag
M2 antibody (Sigma, F1804) and mouse anti-b actin antibody (Bos-
ter, BM0627) were used.
2.4. Electrophoretic mobility shift assay (EMSA)
Approximately 1 ng of the probe was incubated together with
either 100 ng of full length GST-tagged Cdk1 or Oct4 protein or
10–20 lg of cell extracts for 30 min at 25 C in a ﬁnal volume of
20 ll. For shift assays, 2 lg of the corresponding antibody were
added after 30 min and incubation was continued for 1 h at 4 C.
Subsequently the binding reaction was separated on a 5.5–7% poly-
acrylamide gel in 1 TB 90 mM Tris, 90 mM boric acid.
2.5. Immunoprecipitation
Five hundred microgram protein samples in a total volume of
500 ll were immunoprecipitated with 2 lg of antibody and 20 ll
of Protein-A beads (for rabbit polyclonal antibodies) or Protein-G
beads (for mouse monoclonal antibodies). The samples were ro-
tated at 4 C overnight. The beads were washed 4 with 1 ml of
cold NP40 lysis buffer containing protease inhibitors. The beads
were then boiled for 10 min in the presence of 25 ll 2 sample
buffer and the released proteins fractionated by SDS–PAGE in
12% or 15% gels. Proteins were detected by immunoblotting as de-
scribed above.
2.6. GST pull-down assay
Puriﬁed GST-fusion protein were precleared with GST beads (GE
Healthcare, 17-0756-0), for 1 h and incubated with GST or His-
tagged Oct4 fusion proteins overnight at 4 C. Protein-bound GST
beads were washed 4 with lysis buffer and eluted in SDS–PAGE
sample buffer. Eluted proteins were analyzed by immunoblotting.
2.7. Luciferase reporter assay
Cells were seeded in 24-well plates at a density of 1  105. After
24 h, the cells were transfected using Lipofectamine 2000 (Invitro-
gen). Brieﬂy, luciferase reporter constructs (400 ng), pcDNA–Cdk1
or pcDNA–Oct4 plasmids (400 ng) and the pRL-SV40 Renilla lucif-
erase construct (5 ng) were co-transfected into the wells. Cell ex-
tracts were prepared 48 h after transfection and the luciferase
activity was measured using the Dual-Luciferase reporter assay
system (Promega).
2.8. Immunocytochemistry
ES Cells were ﬁxed with 4% formaldehyde for 30 min, washed
4 over 30 min with PBS + 0.25 g Tween 20 (PBST) and blocked
with 5% horse serum in PBST. Primary mouse anti-Cdk1 (Santa-
Cruz, SC-53219, 1:250) and goat anti-Oct4 (SantaCruz, SC-8628
1:250) antibodies were applied in blocking solution for 1 h. After
washing in PBST, coverslips were incubated with Alexa546-conju-
gated anti-mouse (Molecular Probes, 1:3000) and Alexa488-conju-
gated anti goat (Molecular Probes, 1:2000) secondary antibodies
for 20 min in the presence of DAPI (2 lg/ml) for 20 min before
washing again with PBST and mounting. Images were captured
with a 20 oil emersion objective lens, and all red and all green
images were adjusted identically in order to generate the merge
images.
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Cdk1-depleted and mock-transfected ES cells were cross-linked
with 1% formaldehyde for 10 min at room temperature and form-
aldehyde was then inactivated by the addition of 125 mM glycine.
Chromatin extracts containing DNA fragments with an average size
of 500 bp were immunoprecipitated using anti-Oct4 (sc-8628,
Santa Cruz). PCR analyses were performed for immunoprecipitated
DNA.
3. Result
3.1. Both Oct4 and Cdk1 were highly expressed in undifferentiated es
cells
If Cdk1 functions together with Oct4 through protein–protein
interaction to maintain the undifferentiated state of ES cells, their
expression levels should exhibit a close correlation along with cell
undifferentiation. Thus, we induced ES cells to differentiate by ret-
inoic acid (RA) treatment or LIF withdrawal from the culture med-
ium. Results showed that similar with Oct4, both RA induction and
LIF removal led to reduction in the expression level of Cdk1 (de-
tected by antibody BS1820) (Fig. 1). Since there are different mod-
iﬁcation molecules of Cdk1 including its enzymatic active form
(dephosphorylated at the site of tyrosine 15) and inactive form
(phosphorylated at the site of tyrosine 15), we also proﬁled the
expression level of these molecules. Results showed that the de-
crease of both Oct4 and Cdk1 (whole; active form; inactive form)
was more obvious upon RA treatment than LIF withdrawal. Since
these two assays drive ES cells to differentiate into different lin-
eages, we could conclude that Oct4 and Cdk1 preferably expressed
in pluripotent ES cells, and exhibited similar expression proﬁle
along differentiation.
3.2. Cdk1 can directly interact with Oct4
Although Wang et al. showed an existence of Cdk1 in the Oct4
interactome, a more recent study by Pardo et al. did not observe
Cdk1 in the Oct4 complex [20]. Thus, we were interested to con-
ﬁrm whether these two proteins can interact. Firstly, ES cells were
transfected with expression plasmids inserted with the open read-
ing frame of Cdk1 which was fused with HA-tag at the carboxyl ter-
minus. After 2-day antibiotic selection, the cell lysates were
subjected to immune-precipitation with anti-HA monoclonal
antibody, followed by Western blotting with anti-Oct4 antibody.
Results showed that HA-tagged Cdk1 was successfully overexpres-
sed, while the expression level of Oct4 did not change (Fig. 2A,Fig. 1. Undifferentiated mouse ES cells expressed high levels of Cdk1 and Oct4. ES
cells were treated with 1 lM RA or cultured in LIF-withdrawn medium for 3 and
6 days, respectively. The expression levels of Cdk1 and Oct4 were monitored by
Western blot.lower panel). This observation allowed us to further perform im-
mune-precipitation assay. As shown in Fig. 2A, we observed com-
plex formation between Cdk1 and Oct4 protein. To examine
whether this complex formation with Oct4 is related with the ki-
nase activity of Cdk1, we inserted the open reading frame express-
ing kinase-dead Cdk1 mutant (D146 N) into the same expression
vector [21]. Interestingly, we also detected its association with
Oct4 (Fig 2A), indicating that the interaction between Cdk1 and
Oct4 was independent of Cdk1 kinase activity. To further conﬁrm
the interaction between endogenous Cdk1 and Oct4, the co-
immunoprecipitation assay was carried out by using the lysates
of wild type ES cells, for afﬁnity capture with anti-Cdk1 antibody
and Western blotting with anti-Oct4 antibody. The Cdk1 IP elution
sample was qualiﬁed by the existence of Cyclin A and B1 (Fig. 2B).
As a result, a strong band of Oct4 was detected, showing that Oct4
was co-puriﬁed with Cdk1 (Fig. 2B).
The above studies only conﬁrmed that Cdk1 could be found in
an Oct4 complex. In order to determine whether Cdk1 can directly
associate with Oct4, pull-down assays with Ni–NTA agrose beads
by using puriﬁed Cdk1 and Oct4 Protein were performed. Bacteri-
ally expressed His–Oct4 fusion protein was captured by Ni–NTA
beads and incubated with puriﬁed GST–Cdk1 fusion protein. GST-
Sox2 fusion protein was used as a positive control, since Sox2 is
a well-established Oct4 partner [22]. Interaction between Oct4
and Sox2 was observed (Fig. 2C, right panel). Importantly, GST-
tagged Cdk1 was successfully pulled down by His-tagged Oct4,
but not the GST mock protein (Fig. 2C, left panel), which showed
that Cdk1 protein can physically bind to Oct4 through a direct pro-
tein–protein association. It was reported that Cdk1 shares high
identity in sequence with other Cdk members, such as Cdk2 and
Cdk4. Moreover, their function seems to partially compensate
[23]. Therefore, we were interested to investigate whether Cdk2/
4 could similarly interact with Oct4. To achieve this, similar exper-
iments with ﬁgure 2C were performed by using puriﬁed Oct4 and
Cdk2/4 protein. Neither Cdk2 nor Cdk4 was able to form complex
with Oct4 (Fig. 2D, left and middle panel). We also carried out
the Oct4 IP experiment and did not identify a direct physical asso-
ciation between them (Fig. 2D, right panel).
To further explore the interaction between Cdk1 and Oct4 in
self-renewing ES cells in vivo, we performed the Immunocyto-
chemistry assay. Importantly, most cells exhibited foci formed by
Cdk1 and Oct4 co-localization (Fig. 3).
3.3. Cdk1 enhanced the suppression of Cdx2 transcription by Oct4
It was reported that Oct4 can inhibit the gene activity of Cdx2
through direct binding to its promoter [11]. Therefore, we asked
whether the formation of Cdk1–Oct4 complex can inﬂuence
binding of Oct4 on the Cdx2 promoter. To answer this question,
electrophoretic mobility shift assay (EMSA) was performed using
a biotin-labeled double-stranded oligonucleotide probe, a 40-bp
sequence from the Cdx2 proximal promoter containing the Oct4
binding consensus. Puriﬁed GST–Oct4 protein (lane 3), but neither
GST nor GST–Cdk1, shifted the Cdx2 probe, indicating the forma-
tion of Cdx2 probe–Oct4 complex (Fig. 4A). Interestingly, although
Cdk1 alone failed in associating with the probe, the bands
representing shifted Cdx2 probe–Oct4 complex was signiﬁcantly
enhanced by addition of puriﬁed GST–Cdk1. Moreover, more puri-
ﬁed GST–Cdk1 was added, more shifted bands were observed (lane
6–7, Fig. 4A). Meanwhile, compared with the wild-type Cdk1, ki-
nase-dead Cdk1 mutant exhibited similar activity in enhancing
Oct4 binding on the Cdx2 promoter (lanes 8 and 9, Fig. 4A), which
was consistent with the capability of Cdk1 mutant in interacting
with Oct4 (Fig. 2A). This observation showed that Cdk1 could not
directly bind to the Cdx2 promoter. However, it enhanced the
binding of Oct4 on the Cdx2 gene.
Fig. 2. Cdk1 directly interacted with Oct4. (A) The interaction between Cdk1 and Oct4 was detected in Cdk1or Cdk1 mutant-overexpressed ES cells. ES cells were transfected
with pcDNA-HA expression vectors encoding Cdk1 or Cdk1 kinase-dead mutant. Whole cell extracts were prepared 48 h after transfection. To monitor the expression level of
exogenous Cdk1 or Cdk1 mutant and endogenous Oct4, the extracts were analyzed by Western blotting with the antibodies against HA and Oct4 respectively (lower panels).
The extracts were further immunoprecipitated with anti-HA monoclonal antibody, followed by Western blotting with anti-Oct4 monoclonal antibody (upper panel). (B) The
interaction between endogenous Cdk1 and Oct4 was detected in wild type ES cells. Extracts of ES cells were immunoprecipitated with anti-Cdk1 antibody or mouse IgG,
followed by Western blotting with the anti-Oct4 antibody. Cyclin A and Cyclin B1 were used as positive controls. (C) In vitro examination of Cdk1–Oct4 complex formation
through the pull-down assay. Ni–NTA agarose beads were used to bind His-tagged Oct4 so as to capture GST-tagged Cdk1 puriﬁed from bacteria extracts. GST-tagged Sox2
was used as a positive control. (D) Cdk2 and Cdk4 failed to associate with Oct4. Ni–NTA agarose beads were used to bind His-tagged Oct4 so as to capture GST-tagged Cdk2
(middle panel) and Cdk4 (left panel) puriﬁed from bacteria extracts and followed by GST-pull down assay. Extracts of ES cells were immunoprecipitated with anti-Oct4
antibody or mouse IgG, followed by Western blotting with the antibodies against Cdk2 and Cdk4 respectively. The antibody against Sox2 was used as a positive control (right
panel).
Fig. 3. The immunocytochemistry assay was performed to detect the foci formed by Cdk1 and Oct4 co-localization. The subcellular localization of endogenous Oct4 (green)
and Cdk1 (red) was analyzed by immunocytochemistry in ES cells. Cell nuclei were stained with DAPI (40,6-diamidino-2-phenylindole, blue). Images were captured with 20
and 40 immersion objective lenses.
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Fig. 4. Cdk1 enhanced the transcription repression of Cdx2 by interacting with Oct4. (A) Puriﬁed GST–Oct4 was incubated with either probe alone or increased amount of
puriﬁed GST–Cdk1 or GST–Cdk1 mutant (kinase-dead), followed by the EMSA with the probe designed from the Cdx2 promoter with known Oct4 binding site (upper panel).
AlphaEaseFC (Alpha Innotech) software was used to quantify the density of shifted bands formed by protein and probe association (lower panel). (B) Mouse ES cells were
transfected with Cdk1 depletion construct, Oct4 depletion construct or both. Levels of Cdk1 or Oct4 after knockdown were determined by real-time RT-PCR (right panel).
Cdk1-depleted, Oct4-depleted or Cdk1/Oct4 double-depleted cell lysates were incubated with the Cdx2 probe and followed by the EMSA (left panel). (C) The Cdx2
promoter–Luciferase reporter was co-transfected to 293 cell line with the constructs over-expressing HA-tagged Cdk1 or Cdk1 mutant together with the one over-expressing
Flag-tagged Oct4. Single overexpression of Cdk1, Cdk1 mutant or Oct4 was also used to explore their effect on regulating the Cdx2 promoter activity. Fourty eight hour after
transfection, luciferase activities were determined (upper panel). The data was normalized to the activity of cells transfected with the empty vector (pGL4.2). Western
blotting assay was used to monitor the expression levels of HA-tagged Cdk1 and Flag-tagged Oct4 (lower panel).
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of Cdk1 in the regulation of Cdx2 expression, we generated the
Cdk1-depleted, Oct4-depleted, or Cdk1 and Oct4 double depleted
ES cells to further explore how Cdk1 was involved in Oct4-medi-
ated transcription regulation of Cdx2. Three days after transfection,
whole cell lysates were harvested. The knockdown constructs efﬁ-
ciently reduced endogenous Cdk1 and Oct4 mRNA by about 80%
and 90%, respectively (Fig. 4B, right panel). Western blotting anal-
ysis further conﬁrmed the successful depletion of these two genes,
while Oct4 expression level was not affected upon Cdk1 knock-
down (data not shown; [16]). We further used these cell lysates
to perform EMSA. As shown in Fig. 4B, compared with wild type
ES cells, both Cdk1 depletion and Oct4 depletion resulted in a de-crease in Oct4-Cdx2 probe formation (lanes 3 and 4). Furthermore,
knockdown Cdk1 in the Oct4-depleted ES cells led to a further de-
crease in the formation of probe-protein complex by 82% (lane 5).
We concluded that although Cdk1 alone could not associate with
Cdx2, the interaction between Cdk1 and Oct4 allowed Cdk1 to en-
hance the binding of Oct4 on Cdx2 gene.
Our previous study showed that the expression of Cdx2 was in-
duced signiﬁcantly upon the knockdown of Cdk1 [16]. Therefore,
the next question of interest was whether Cdk1 depletion-induced
Cdx2 repression was due to its interaction with Oct4. To answer
this question, we carried out luciferase assay with the reporter
harboring the Cdx2 promoter (PCdx2–Luc). The PCdx2–Luc was co-
transfected to 293 cell line with the constructs overexpressing
Fig. 5. The role of Cdk1 involved in Oct4-mediated transcription regulating in ES cells was Cyclin-independent. (A) The interaction between endogenous Oct4 with Cyclin A/B
was not detected. Extracts of ES cells were immunoprecipitated with anti-Oct4 antibody or mouse IgG, followed by Western blotting with the antibodies against Cyclin A/B.
Sox2 was used as a positive control as the known Oct4 partner. (B) Mouse ES cells were transfected with Cyclin A depletion construct or Cyclin B1 depletion construct. Levels of
gene expression were determined by real-time RT-PCR (right panel). Cell lysates with depleted Cyclin A, or Cyclin B1 were incubated with the Cdx2 probe containing Oct4
binding site and followed by an EMSA.
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expressing Flag-tagged Oct4. Single overexpression of Cdk1, Cdk1
mutant or Oct4 was also used to explore their effect on regulating
the Cdx2 promoter activity. Western blotting assay showed a suc-
cessful overexpression of Cdk1, Cdk1 mutant and Oct4, respec-
tively (Fig. 4C). Upon Cdk1 or Oct4 overexpression, the activity of
Cdx2 promoter dramatically decreased by about 30% and 40%,
respectively, and Cdk1 mutant exhibited similar effect with the
wild-type Cdk1 on inhibiting the promoter (Fig. 4C). Furthermore,
when we overexpressed either Cdk1 or Cdk1 mutant in Oct4-over-
expressed ES cells, the activity of Cdx2 promoter was further de-
creased by about 70% compared with control (Fig. 4C). These
results demonstrated that Cdk1–Oct4 complex formation signiﬁ-
cantly enhanced the repressive role of Oct4 in regulating Cdx2 pro-
moter activity. Moreover, this regulation was independent on the
kinase activity of Cdk1.
The next question we were interested to address was whether
the role of Cdk1 in ES cells was cell cycle-autonomous. Cyclin A
and Cyclin B1 are known partners of Cdk1 in the process of cell cy-
cle regulation [24]. Thus, we designed experiments to explore
whether these two Cyclin proteins held similar role with Cdk1 in
regulating Oct4-mediated Cdx2 repression. Firstly, we performed
Oct4 immunoprecipitation experiment and found that neither Cy-
clin A nor Cyclin B1 was detected in the Oct4 complex (Fig. 5A).
Furthermore, we generated Cyclin A- or Cyclin B1-depleted ES cellextract for the EMSA. Our result showed Cyclin A or Cyclin B deple-
tion did not change Oct4 binding on Cdx2 promoter (Fig. 5B).
Combining the results uncovered by the luciferase assay and
EMSA experiment, we concluded that the interaction between
Cdk1 and Oct4 is required by the Oct4-mediated transcriptional
suppression of Cdx2. Base on our ﬁndings, a model was generated
(Fig. 6B). Cdk1 can directly interact with Oct4 to enhance the tran-
scriptional inhibition of Cdx2 by Oct4. As a result, ES cells main-
tained the propertied and stopped to differentiate to
trophectoderm lineage.
4. Discussion
In eukaryotic cells, the cell cycle is controlled by Cdks and their
binding partners, Cyclins [13]. In early G1 phase, Cdk4 and/or Cdk6
are activated by D-type Cyclins and initiate phosphorylation of the
Retinoblastoma protein (Rb) family and release E2F [24,25]. During
the G2/M transition, Cdk1/Cyclin A activity is required for the ini-
tiation of prophase [26]. Finally, Cdk1/Cyclin B complex actively
participates and completes mitosis [27]. Compared with the nor-
mal cells, ES cells have a short cell cycle (around 11 h), primarily
owing to a short G1 phase [28]. The Rb protein keeps hyperphos-
phorylated and maintains inactive throughout the cell cycle,
resulting in constitutive E2F activation and subsequent transcrip-
tion of its target genes. This explains the G1/S checkpoint absence
Fig. 6. Cdk1 enhanced Oct4-mediated transcription repression of trophectoderm
markers and thus was involved into inhibiting ES cell differentiation into troph-
ectoderm. (A) Chromatin Immunoprecipitation assay was used to analyze the effect
of Cdk1 depletion on Oct4’s binding on trophectoderm marker Cdx2 and Fgfr2. Cdk1
depleted-ES cell Chromatin extract was immunoprecipitated with the Oct4
antibody, and eluted DNA samples were then ampliﬁed using primers for the
proximal promoter of Cdx2 or the ﬁrst intron of Fgfr2. Mock depletion sample was
used as control. (B) Schematic representation of the interplay between Cdk1 and
Oct4 in ES cells. Cdk1 can directly interact with Oct4 to enhance its inhibition of
Cdx2 transcript, consequently maintaining the properties of ES cells while blocking
cell differentiation into the trophectoderm lineage.
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Cdk1 is highly overexpressed in pluripotent stem cells when com-
pared with somatic cells [29]. This indicates the involvement of
Cdk1 in regulating cell differentiation, which has been conﬁrmed
by recent studies. Ullah et al. reported that RO3306-mediated
Cdk1 inhibition stops cell cycle transition into mitosis, and thus in-
duced differentiation of trophectoderm stem cells into giant cells
[15]. Zhang et al. used RNA interference assay to demonstrate that
Cdk1 depletion leads to ES cells arrest at G2 phase and conse-
quently apoptosis [16]. Consistently, Cdk1 deletion leads to early
embryonic lethality [14]. Although the Cdk1-depleted ES cells have
been characterized, how Cdk1 maintains the normal self-renewing
undifferentiated status of the ES cells remained unclear. This study
demonstrated the direct interaction between Cdk1 and Oct4. More
importantly, transcriptional repression of Cdx2 by Oct4 was depen-
dent on the Cdk1–Oct4 complex formation. This ﬁnding is consis-
tent with previous observation that Cdk1-depleted ES cells
exhibit a dramatic increase in Cdx2 transcript [16].
As shown by our previous study, Cdx2 is one of the highlighted
genes whose expression shows signiﬁcant changed [16]. For exam-
ple, Mesoendoderm marker Msx1 and ectoderm Fgf5 are also
greatly up-regulated upon Cdk1 depletion. The reason for us to fo-
cus on Cdx2 is that it is a well established target of Oct4 although
genome-wide chromatin-immunoprecipitation (ChIP)-sequencing
results have shown Msx1 and Fgf5 among the Oct4 target gene list
[30]. On the other hand, Oct4 is the key inhibitor to stop ES cells
differentiating into Cdx2-marked trophectoderm [6]. As a pro-
tein–protein interaction partner of Oct4, the induction of Cdx2
upon Cdk1 depletion supports the possibility that Cdk1 and Oct4
function in repressing trophectoderm differentiation through the
Cdk1–Oct4 complex formation. To conﬁrm this, we further per-
formed in vivo ChIP assay with Cdk1-depleted ES cells and found
that Cdk1 depletion signiﬁcantly reduced Oct4’s binding on Cdx2
and another trophectoderm marker, Fgfr2 (Fig. 6A). Besides differ-
entiation marker genes, a list of self-renewal related genes, such asSox2, Esrrb, Tdgf1 and Tcl1, show down-regulated in Cdk1 knock-
down ES cells [16]. Of note, these genes are binding targets of
Oct4 [30]. Thus, whether Cdk1 is involved in promoting Oct4’s acti-
vation of these genes remains to be answered.
Different post-translational modiﬁcations of Oct4 have been
identiﬁed. For example, E3 ubiquitin ligase Wwp2 can mediate
ubquitination of Oct4 to enhance its instability in ES cells [31]. Po-
tential protein kinase A (PKA) phosphorylates serine 229 of Oct4
[32]. Other phosphorylation sites of Oct4 were also identiﬁed
[33]. These modiﬁcations may serve to inﬂuence Oct4 homo- or
heterodimer formation, consequently inﬂuencing its transcrip-
tional regulation of downstream targets. Although Cdk1 is a well-
known kinase required by the procession of eukaryotic cell cycle,
the direct association of Oct4 with Cdk1 may not promise an effec-
tive phosphorylation. Several ﬁndings from this study can be as
evidences. Firstly, Cdk1 interacted with Oct4 in a kinase-indepen-
dent manner. And kinase-dead mutation in Cdk1 did not inﬂuence
its interplay with Oct4 in regulating Cdx2 transcription. Secondly,
neither Cyclin A nor Cyclin B1 was associated with the Oct4 inter-
actome. Moreover, these two factors did not involve in Oct4-med-
iated Cdx2 repression. Thus, we presented a novel role of Cdk1 with
kinase- and Cyclin-independence in ES cells. Further investigation
along this line will be of great interest to the ﬁeld.
In conclusion, our study conﬁrmed the direct interaction of
Cdk1 and Oct4. Moreover, this interaction promoted the binding
of Oct4 on the Cdx2 promoter and enhanced Oct4’s repression on
Cdx2 gene activity. These ﬁndings enriched our understanding of
how Cdk1 collaborates with transcription factor Oct4 to inhibit dif-
ferentiation of ES cells into trophectoderm, and thus maintains the
undifferentiated state of ES cells.
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